Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study Group
<p>Abstract</p> <p>Background</p> <p>To determine the characteristics of clinical care offered to type 1 diabetic patients across the four distinct regions of Brazil, with geographic and contrasting socioeconomic differences. Glycemic control, prevalence of cardiovascul...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-10-01
|
Series: | Diabetology & Metabolic Syndrome |
Subjects: | |
Online Access: | http://www.dmsjournal.com/content/4/1/44 |
id |
doaj-e7ce7ed5ac2c49a0887bc1e80e5633de |
---|---|
record_format |
Article |
spelling |
doaj-e7ce7ed5ac2c49a0887bc1e80e5633de2020-11-24T21:35:38ZengBMCDiabetology & Metabolic Syndrome1758-59962012-10-01414410.1186/1758-5996-4-44Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study GroupGomes Marília BCobas Roberta AMatheus Alessandra STannus Lucianne RNegrato CarlosRodacki MelanieBraga NeuzaCordeiro Marilena MLuescher Jorge LBerardo Renata SNery MarciaMarques MariadoCarmo ACalliari Luiz ENoronha Renata MManna Thais DZajdenverg LenitaSalvodelli RobertaPenha Fernanda GFoss Milton CFoss-Freitas Maria CPires Antonio CRobles Fernando CGuedes MariadeFátimaSDib Sergio ADualib PatriciaSilva Saulo CSepulvida JaniceAlmeida Henriqueta GSampaio EmersonRea RosangelaFaria Ana Cristina RTschiedel BalduinoLavigne SuzanaCardozo Gustavo AAzevedo Mirela JCanani LuisZucatti Alessandra TCoral Marisa Helena CPereira DanielaAraujo LuizTolentino MonicaPedrosa Hermelinda CPrado Flaviane ARassi NelsonAraujo Leticia BFonseca Reine Marie CGuedes Alexis DMatos Odelissa SFaria ManuelAzulay RossanaForti Adriana CFaçanha CristinaMontenegro AnaMontenegro RenanMelo Naira HRezende Karla FRamos AlbertoFelicio JoãoSantos Flavia MJezini Deborah LCordeiro Marilena M<p>Abstract</p> <p>Background</p> <p>To determine the characteristics of clinical care offered to type 1 diabetic patients across the four distinct regions of Brazil, with geographic and contrasting socioeconomic differences. Glycemic control, prevalence of cardiovascular risk factors, screening for chronic complications and the frequency that the recommended treatment goals were met using the American Diabetes Association guidelines were evaluated<b>.</b></p> <p>Methods</p> <p>This was a cross-sectional, multicenter study conducted from December 2008 to December 2010 in 28 secondary and tertiary care public clinics in 20 Brazilian cities in north/northeast, mid-west, southeast and south regions. The data were obtained from 3,591 patients (56.0% females and 57.1% Caucasians) aged 21.2 ± 11.7 years with a disease duration of 9.6 ± 8.1 years (<1 to 50 years).</p> <p>Results</p> <p>Overall, 18.4% patients had HbA1c levels <7.0%, and 47.5% patients had HbA1c levels ≥ 9%. HbA1c levels were associated with lower economic status, female gender, age and the daily frequency of self-blood glucose monitoring (SBGM) but not with insulin regimen and geographic region. Hypertension was more frequent in the mid-west (32%) and north/northeast (25%) than in the southeast (19%) and south (17%) regions (p<0.001). More patients from the southeast region achieved LDL cholesterol goals and were treated with statins (p<0.001). Fewer patients from the north/northeast and mid-west regions were screened for retinopathy and nephropathy, compared with patients from the south and southeast. Patients from the south/southeast regions had more intensive insulin regimens than patients from the north/northeast and mid-west regions (p<0.001). The most common insulin therapy combination was intermediate-acting with regular human insulin, mainly in the north/northeast region (p<0.001). The combination of insulin glargine with lispro and glulisine was more frequently used in the mid-west region (p<0.001). Patients from the north/northeast region were younger, non-Caucasian, from lower economic status, used less continuous subcutaneous insulin infusion, performed less SBGM and were less overweight/obese (p<0.001).</p> <p>Conclusions</p> <p>A majority of patients, mainly in the north/northeast and mid-west regions, did not meet metabolic control goals and were not screened for diabetes-related chronic complications. These results should guide governmental health policy decisions, specific to each geographic region, to improve diabetes care and decrease the negative impact diabetes has on the public health system.</p> http://www.dmsjournal.com/content/4/1/44Type 1 diabetesGlycemic controlCardiovascular risk factorsChronic complicationsEconomic status |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Gomes Marília B Cobas Roberta A Matheus Alessandra S Tannus Lucianne R Negrato Carlos Rodacki Melanie Braga Neuza Cordeiro Marilena M Luescher Jorge L Berardo Renata S Nery Marcia Marques MariadoCarmo A Calliari Luiz E Noronha Renata M Manna Thais D Zajdenverg Lenita Salvodelli Roberta Penha Fernanda G Foss Milton C Foss-Freitas Maria C Pires Antonio C Robles Fernando C Guedes MariadeFátimaS Dib Sergio A Dualib Patricia Silva Saulo C Sepulvida Janice Almeida Henriqueta G Sampaio Emerson Rea Rosangela Faria Ana Cristina R Tschiedel Balduino Lavigne Suzana Cardozo Gustavo A Azevedo Mirela J Canani Luis Zucatti Alessandra T Coral Marisa Helena C Pereira Daniela Araujo Luiz Tolentino Monica Pedrosa Hermelinda C Prado Flaviane A Rassi Nelson Araujo Leticia B Fonseca Reine Marie C Guedes Alexis D Matos Odelissa S Faria Manuel Azulay Rossana Forti Adriana C Façanha Cristina Montenegro Ana Montenegro Renan Melo Naira H Rezende Karla F Ramos Alberto Felicio João Santos Flavia M Jezini Deborah L Cordeiro Marilena M |
spellingShingle |
Gomes Marília B Cobas Roberta A Matheus Alessandra S Tannus Lucianne R Negrato Carlos Rodacki Melanie Braga Neuza Cordeiro Marilena M Luescher Jorge L Berardo Renata S Nery Marcia Marques MariadoCarmo A Calliari Luiz E Noronha Renata M Manna Thais D Zajdenverg Lenita Salvodelli Roberta Penha Fernanda G Foss Milton C Foss-Freitas Maria C Pires Antonio C Robles Fernando C Guedes MariadeFátimaS Dib Sergio A Dualib Patricia Silva Saulo C Sepulvida Janice Almeida Henriqueta G Sampaio Emerson Rea Rosangela Faria Ana Cristina R Tschiedel Balduino Lavigne Suzana Cardozo Gustavo A Azevedo Mirela J Canani Luis Zucatti Alessandra T Coral Marisa Helena C Pereira Daniela Araujo Luiz Tolentino Monica Pedrosa Hermelinda C Prado Flaviane A Rassi Nelson Araujo Leticia B Fonseca Reine Marie C Guedes Alexis D Matos Odelissa S Faria Manuel Azulay Rossana Forti Adriana C Façanha Cristina Montenegro Ana Montenegro Renan Melo Naira H Rezende Karla F Ramos Alberto Felicio João Santos Flavia M Jezini Deborah L Cordeiro Marilena M Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study Group Diabetology & Metabolic Syndrome Type 1 diabetes Glycemic control Cardiovascular risk factors Chronic complications Economic status |
author_facet |
Gomes Marília B Cobas Roberta A Matheus Alessandra S Tannus Lucianne R Negrato Carlos Rodacki Melanie Braga Neuza Cordeiro Marilena M Luescher Jorge L Berardo Renata S Nery Marcia Marques MariadoCarmo A Calliari Luiz E Noronha Renata M Manna Thais D Zajdenverg Lenita Salvodelli Roberta Penha Fernanda G Foss Milton C Foss-Freitas Maria C Pires Antonio C Robles Fernando C Guedes MariadeFátimaS Dib Sergio A Dualib Patricia Silva Saulo C Sepulvida Janice Almeida Henriqueta G Sampaio Emerson Rea Rosangela Faria Ana Cristina R Tschiedel Balduino Lavigne Suzana Cardozo Gustavo A Azevedo Mirela J Canani Luis Zucatti Alessandra T Coral Marisa Helena C Pereira Daniela Araujo Luiz Tolentino Monica Pedrosa Hermelinda C Prado Flaviane A Rassi Nelson Araujo Leticia B Fonseca Reine Marie C Guedes Alexis D Matos Odelissa S Faria Manuel Azulay Rossana Forti Adriana C Façanha Cristina Montenegro Ana Montenegro Renan Melo Naira H Rezende Karla F Ramos Alberto Felicio João Santos Flavia M Jezini Deborah L Cordeiro Marilena M |
author_sort |
Gomes Marília B |
title |
Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study Group |
title_short |
Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study Group |
title_full |
Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study Group |
title_fullStr |
Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study Group |
title_full_unstemmed |
Regional differences in clinical care among patients with type 1 diabetes in Brazil: Brazilian Type 1 Diabetes Study Group |
title_sort |
regional differences in clinical care among patients with type 1 diabetes in brazil: brazilian type 1 diabetes study group |
publisher |
BMC |
series |
Diabetology & Metabolic Syndrome |
issn |
1758-5996 |
publishDate |
2012-10-01 |
description |
<p>Abstract</p> <p>Background</p> <p>To determine the characteristics of clinical care offered to type 1 diabetic patients across the four distinct regions of Brazil, with geographic and contrasting socioeconomic differences. Glycemic control, prevalence of cardiovascular risk factors, screening for chronic complications and the frequency that the recommended treatment goals were met using the American Diabetes Association guidelines were evaluated<b>.</b></p> <p>Methods</p> <p>This was a cross-sectional, multicenter study conducted from December 2008 to December 2010 in 28 secondary and tertiary care public clinics in 20 Brazilian cities in north/northeast, mid-west, southeast and south regions. The data were obtained from 3,591 patients (56.0% females and 57.1% Caucasians) aged 21.2 ± 11.7 years with a disease duration of 9.6 ± 8.1 years (<1 to 50 years).</p> <p>Results</p> <p>Overall, 18.4% patients had HbA1c levels <7.0%, and 47.5% patients had HbA1c levels ≥ 9%. HbA1c levels were associated with lower economic status, female gender, age and the daily frequency of self-blood glucose monitoring (SBGM) but not with insulin regimen and geographic region. Hypertension was more frequent in the mid-west (32%) and north/northeast (25%) than in the southeast (19%) and south (17%) regions (p<0.001). More patients from the southeast region achieved LDL cholesterol goals and were treated with statins (p<0.001). Fewer patients from the north/northeast and mid-west regions were screened for retinopathy and nephropathy, compared with patients from the south and southeast. Patients from the south/southeast regions had more intensive insulin regimens than patients from the north/northeast and mid-west regions (p<0.001). The most common insulin therapy combination was intermediate-acting with regular human insulin, mainly in the north/northeast region (p<0.001). The combination of insulin glargine with lispro and glulisine was more frequently used in the mid-west region (p<0.001). Patients from the north/northeast region were younger, non-Caucasian, from lower economic status, used less continuous subcutaneous insulin infusion, performed less SBGM and were less overweight/obese (p<0.001).</p> <p>Conclusions</p> <p>A majority of patients, mainly in the north/northeast and mid-west regions, did not meet metabolic control goals and were not screened for diabetes-related chronic complications. These results should guide governmental health policy decisions, specific to each geographic region, to improve diabetes care and decrease the negative impact diabetes has on the public health system.</p> |
topic |
Type 1 diabetes Glycemic control Cardiovascular risk factors Chronic complications Economic status |
url |
http://www.dmsjournal.com/content/4/1/44 |
work_keys_str_mv |
AT gomesmariliab regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT cobasrobertaa regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT matheusalessandras regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT tannuslucianner regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT negratocarlos regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT rodackimelanie regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT braganeuza regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT cordeiromarilenam regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT luescherjorgel regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT berardorenatas regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT nerymarcia regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT marquesmariadocarmoa regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT calliariluize regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT noronharenatam regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT mannathaisd regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT zajdenverglenita regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT salvodelliroberta regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT penhafernandag regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT fossmiltonc regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT fossfreitasmariac regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT piresantonioc regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT roblesfernandoc regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT guedesmariadefatimas regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT dibsergioa regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT dualibpatricia regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT silvasauloc regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT sepulvidajanice regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT almeidahenriquetag regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT sampaioemerson regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT rearosangela regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT fariaanacristinar regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT tschiedelbalduino regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT lavignesuzana regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT cardozogustavoa regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT azevedomirelaj regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT cananiluis regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT zucattialessandrat regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT coralmarisahelenac regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT pereiradaniela regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT araujoluiz regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT tolentinomonica regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT pedrosahermelindac regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT pradoflavianea regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT rassinelson regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT araujoleticiab regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT fonsecareinemariec regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT guedesalexisd regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT matosodelissas regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT fariamanuel regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT azulayrossana regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT fortiadrianac regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT facanhacristina regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT montenegroana regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT montenegrorenan regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT melonairah regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT rezendekarlaf regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT ramosalberto regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT feliciojoao regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT santosflaviam regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT jezinideborahl regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup AT cordeiromarilenam regionaldifferencesinclinicalcareamongpatientswithtype1diabetesinbrazilbraziliantype1diabetesstudygroup |
_version_ |
1725944755920044032 |